Concepedia

ES Daar

ED

2

Publications

73

Citations

2

H-Index

2008

Active since

Affiliations

Harbor–UCLA Medical Center(Current)

The Lundquist Institute

ES Daar is an author at Harbor–UCLA Medical Center.

Publications per year

2008–2018

2

Publications

2

Switching to coformulated rilpivirine (<scp>RPV</scp>), emtricitabine (<scp>FTC</scp>) and tenofovir alafenamide from either <scp>RPV</scp>,<scp> FTC</scp> and tenofovir disoproxil fumarate (<scp>TDF</scp>) or efavirenz, <scp>FTC</scp> and <scp>TDF</scp>: 96‐week results from two randomized clinical trials

D Hagins, Chloe Orkin, ES Daar et al. · HIV Medicine · 2018 · 47 citations · Full text

The prevalence of transmitted antiretroviral drug resistance in treatment‐naïve patients and factors influencing first‐line treatment regimen selection

H.‐Y. HUANG, ES Daar, Barnaby Edward Young et al. · HIV Medicine · 2008 · 26 citations

Rows per page

1–2 of 2